PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Worst Case Consideration, page-22

  1. 200 Posts.
    lightbulb Created with Sketch. 383
    Just to clarify, I am not a doctor (of medicine. I am a doctor of chemistry, fwiw).

    I don’t see a problem with a doctor prescribing IPPS for pain relief since that is the headline therapeutic outcome. That it gets there by a regenerative mechanism rather than blocking pain signaling is a separate matter. Of course treating pain by addressing the root cause is far more desirable.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.